l carnitine tmao nature medicine 2013 koeth

l carnitine tmao nature medicine 2013 koeth γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to Frontiers | Gut Metabolite Trimethylamine-N-Oxide

Name: l carnitine tmao nature medicine 2013 koeth γ–Butyrobetaine is a pro-atherogenic intermediate in gut microbial metabolism of L-carnitine to Frontiers | Gut Metabolite Trimethylamine-N-Oxide
Brand: centoria.fr
SKU: 68010229158
Price: 28.40 USD
Availability: InStock
Rating: 4.8217 (10 reviews)

Frontiers Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy A systematic review of TMAO, microRNAs, and the oral gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities Journal of Translational Medicine Springer Nature Link Gut microbiota derived metabolites in cardiovascular health and disease Protein & Cell Springer Nature Link Trimethylamine N Oxide and Related Gut Microbe Derived Metabolites and Incident Heart Failure Development in Community Based Populations Circulation: Heart Failure

SKU: 68010229158 · From centoria.fr

4.8

USD28.40 USD48.40

Pay in 4 interest-free payments of $7.10 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

3.1 Detoxification and the Management of Acute MUD Withdrawal Symptoms The level of tolerance that can develop to methamphetamine, and the severity of the withdrawal syndrome that occurs following abrupt cessation of heavy use, is an important and underappreciated aspect of methamphetamine use disorder that implies a need for pharmacological management